Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers

Table 7

Positive rate of serum p53 antibody and p53 overexpression.

	Pancreatic cancer	Biliary tract cancer	Pancreatobiliary cancer
p53 antibody	0/35 (0%)	0/12 (0%)	0/47 (0%)
p53 overexpression	7/16 (43.7%)	5/9 (55.5%)	12/25 (48.0%)